Related Experiment Videos
[Insulin-like growth factor 1 levels and their association with growth and development in infants aged 1-24 months]
Xin-Li Wang1, Mei-Ru Ge, Wen-Yan Wu
1Department of Pediatrics, Peking University Third Hospital, Beijing 100191, China. xinli-wang1217@yahoo.com.cn
Insights
Serum insulin-like growth factor 1 (IGF-1) levels are closely linked to infant growth. Higher IGF-1 levels correlate with increased weight and height in both preterm and term infants.
Area of Science:
- Pediatric Endocrinology
- Growth and Development Studies
- Biomarker Research
Context:
- Understanding infant growth is crucial for identifying developmental issues.
- Insulin-like Growth Factor 1 (IGF-1) plays a vital role in postnatal development.
- Variations in IGF-1 levels may indicate differences in growth trajectories between preterm and term infants.
Purpose:
- To investigate serum insulin-like growth factor 1 (IGF-1) levels in infants aged 1-24 months.
- To determine the association between IGF-1 levels and physical growth (weight and length).
- To compare IGF-1 levels in preterm versus term infants during early development.
Summary:
- Serum IGF-1 levels were measured in 525 healthy infants (125 preterm, 400 term) at multiple time points from 1.5 to 24 months.
- IGF-1 levels were lowest in preterm infants at 1.5 months but higher than term infants between 4-12 months.
- IGF-1 levels showed a positive correlation with both weight and height (SDS) in all infants.
Impact:
- Serum IGF-1 levels are a significant indicator of infant growth and development.
- Findings provide normative data for IGF-1 in early childhood.
- This research can aid in the early detection of growth abnormalities.
Objective:
To study serum insulin-like growth factor 1 (IGF-1) levels and their association with growth and development in infants aged 1-24 mouths.
Methods:
A total of 525 healthy infants (125 preterm, 400 term) were enrolled. Serum IGF-1 levels were measured using ELISA 1.5, 4, 6, 8, 12, 18 and 24 months after birth. The body weight and body length were simultaneously measured.
Results:
Serum IGF-1 levels were the lowest in preterm infants 1.5 months after birth (86+/-60 ng/mL). Thereafter, serum IGF-1 levels increased, and were significantly higher than those in term infants between 4 and 12 months after birth. Serum IGF-1 levels in term infants were the highest (116+/-52 ng/mL) 1.5 months after birth during their life of 12 months old. Thereafter, serum IGF-1 levels decreased and reached to a nadir (69+/-58 ng/mL) 8 months after birth. IGF-I levels were positively correlated with the weight and the height (SDS) in both preterm and term infants.
Conclusions:
Serum IGF-1 levels are closely associated with growth and development in infants.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Diabetes Mellitus: Type 2 and Gestational
Insulin Secretory Vesicles
Regulation of Angiogenesis and Blood Supply
Nature and Nurture